{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:44:02Z","timestamp":1692704642800},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00105-014-3570-0","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T07:07:57Z","timestamp":1423206477000},"page":"121-130","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetik des Lupus erythematodes"],"prefix":"10.1007","volume":"66","author":[{"given":"Claudia","family":"G\u00fcnther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,7]]},"reference":[{"key":"3570_CR1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","volume":"18","author":"Z Liu","year":"2012","unstructured":"Liu Z, Davidson A (2012) Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 18:871\u2013882","journal-title":"Nat Med"},{"key":"3570_CR2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1610-0387.2007.06554.x","volume":"5","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Sticherling M, Bonsmann G (2007) Clinical manifestations of cutaneous lupus erythematosus. J Dtsch Dermatol Ges 5:1124\u20131137","journal-title":"J Dtsch Dermatol Ges"},{"key":"3570_CR3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/rheumatology\/ken247","volume":"47","author":"B Rhodes","year":"2008","unstructured":"Rhodes B, Vyse TJ (2008) The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 47:1603\u20131611","journal-title":"Rheumatology (Oxford)"},{"key":"3570_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/gene.2009.39","volume":"10","author":"KL Moser","year":"2009","unstructured":"Moser KL, Kelly JA, Lessard CJ et al (2009) Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10:373\u2013379","journal-title":"Genes Immun"},{"key":"3570_CR5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.46.6.457","volume":"46","author":"JS Smolen","year":"1987","unstructured":"Smolen JS, Klippel JH, Penner E et al (1987) HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 46:457\u2013462","journal-title":"Ann Rheum Dis"},{"key":"3570_CR6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.clim.2013.10.006","volume":"149","author":"G Fousteri","year":"2013","unstructured":"Fousteri G, Liossis SN, Battaglia M (2013) Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol 149:556\u2013565","journal-title":"Clin Immunol"},{"key":"3570_CR7","first-page":"1559","volume":"35","author":"P Lopez","year":"2008","unstructured":"Lopez P, Gomez J, Prado C et al (2008) Influence of functional interleukin 10\/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J Rheumatol 35:1559\u20131566","journal-title":"J Rheumatol"},{"key":"3570_CR8","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar4566","volume":"16","author":"AL Roberts","year":"2014","unstructured":"Roberts AL, Thomas ER, Bhosle S et al (2014) Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases. Arthritis Res Ther 16:R114","journal-title":"Arthritis Res Ther"},{"key":"3570_CR9","doi-asserted-by":"crossref","first-page":"15838","DOI":"10.1073\/pnas.1001337107","volume":"107","author":"N Shen","year":"2010","unstructured":"Shen N, Fu Q, Deng Y et al (2010) Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 107:15838\u201315843","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3570_CR10","first-page":"203435","volume":"2014","author":"PS Ramos","year":"2014","unstructured":"Ramos PS, Shaftman SR, Ward RC et al (2014) Genes associated with SLE are targets of recent positive selection. Autoimmune Dis 2014:203435","journal-title":"Autoimmune Dis"},{"key":"3570_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00376120","volume":"27","author":"RA McAdam","year":"1988","unstructured":"McAdam RA, Goundis D, Reid KB (1988) A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual. Immunogenetics 27:259\u2013264","journal-title":"Immunogenetics"},{"key":"3570_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","volume":"76","author":"MC Pickering","year":"2000","unstructured":"Pickering MC, Botto M, Taylor PR et al (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227\u2013324","journal-title":"Adv Immunol"},{"key":"3570_CR13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/507848","volume":"79","author":"MA Lee-Kirsch","year":"2006","unstructured":"Lee-Kirsch MA, Gong M, Schulz H et al (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet 79:731\u2013737","journal-title":"Am J Hum Genet"},{"key":"3570_CR14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/jid.2013.496","volume":"134","author":"K Peschke","year":"2014","unstructured":"Peschke K, Friebe F, Zimmermann N et al (2014) Deregulated type I IFN response in TREX1-associated familial chilblain lupus. J Invest Dermatol 134:1456\u20131459","journal-title":"J Invest Dermatol"},{"key":"3570_CR15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","volume":"85","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch MA, Chowdhury D, Harvey S et al (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med 85:531\u2013537","journal-title":"J Mol Med"},{"key":"3570_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.a.33778","volume":"155A","author":"JC Ravenscroft","year":"2011","unstructured":"Ravenscroft JC, Suri M, Rice GI et al (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet A 155A:235\u2013237","journal-title":"Am J Med Genet A"},{"key":"3570_CR17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","volume":"131","author":"YG Yang","year":"2007","unstructured":"Yang YG, Lindahl T, Barnes DE (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131:873\u2013886","journal-title":"Cell"},{"key":"3570_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","volume":"134","author":"DB Stetson","year":"2008","unstructured":"Stetson DB, Ko JS, Heidmann T et al (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587\u2013598","journal-title":"Cell"},{"key":"3570_CR19","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.1400737","volume":"192","author":"A Ablasser","year":"2014","unstructured":"Ablasser A, Hemmerling I, Schmid-Burgk JL et al (2014) TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 192:5993\u20135997","journal-title":"J Immunol"},{"key":"3570_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cei.12160","volume":"175","author":"MA Lee-Kirsch","year":"2014","unstructured":"Lee-Kirsch MA, Wolf C, Gunther C (2014) Aicardi-Goutieres syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol 175:17\u201324","journal-title":"Clin Exp Immunol"},{"key":"3570_CR21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","volume":"480","author":"DC Goldstone","year":"2011","unstructured":"Goldstone DC, Ennis-Adeniran V, Hedden JJ et al (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379\u2013382","journal-title":"Nature"},{"key":"3570_CR22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow YJ, Hayward BE, Parmar R et al (2006) Mutations in the gene encoding the 3\u2018\u20135\u2018 DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS 1 locus. Nat Genet 38:917\u2013920","journal-title":"Nat Genet"},{"key":"3570_CR23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","volume":"44","author":"GI Rice","year":"2012","unstructured":"Rice GI, Kasher PR, Forte GM et al (2012) Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 44:1243\u20131248","journal-title":"Nat Genet"},{"key":"3570_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","volume":"46","author":"GI Rice","year":"2014","unstructured":"Rice GI, del Toro DY, Jenkinson EM et al (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503\u2013509","journal-title":"Nat Genet"},{"key":"3570_CR25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow YJ, Leitch A, Hayward BE et al (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 38:910\u2013916","journal-title":"Nat Genet"},{"key":"3570_CR26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.27367","volume":"62","author":"G Ramantani","year":"2010","unstructured":"Ramantani G, Kohlhase J, Hertzberg C et al (2010) Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutieres syndrome. Arthritis Rheum 62:1469\u20131477","journal-title":"Arthritis Rheum"},{"key":"3570_CR27","doi-asserted-by":"crossref","first-page":"206730","DOI":"10.1155\/2012\/206730","volume":"2012","author":"JL Schmidt","year":"2012","unstructured":"Schmidt JL, Olivieri I, Vento JM et al (2012) Family history of autoimmune disease in patients with Aicardi-Goutieres syndrome. Clin Dev Immunol 2012:206730","journal-title":"Clin Dev Immunol"},{"key":"3570_CR28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","volume":"39","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch MA, Gong M, Chowdhury D et al (2007) Mutations in the gene encoding the 3\u2018-5\u2018 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39:1065\u20131067","journal-title":"Nat Genet"},{"key":"3570_CR29","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","volume":"43","author":"SM Al-Mayouf","year":"2011","unstructured":"Al-Mayouf SM, Sunker A, Abdwani R et al (2011) Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 43:1186\u20131188","journal-title":"Nat Genet"},{"key":"3570_CR30","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/art.38008","volume":"65","author":"A Belot","year":"2013","unstructured":"Belot A, Kasher PR, Trotter EW et al (2013) Protein kinase cdelta deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum 65:2161\u20132171","journal-title":"Arthritis Rheum"},{"key":"3570_CR31","doi-asserted-by":"crossref","unstructured":"Gunther C, Meurer M, Stein A et al (2009) Familial Chilblain Lupus - A Monogenic Form of Cutaneous Lupus Erythematosus due to a Heterozygous Mutation in TREX1. Dermatology 219(2):162\u2013166","DOI":"10.1159\/000222430"},{"key":"3570_CR32","doi-asserted-by":"crossref","unstructured":"Rice G, Newman WG, Dean J et al (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 80:811\u2013815","DOI":"10.1086\/513443"},{"key":"3570_CR33","doi-asserted-by":"crossref","unstructured":"Tungler V, Silver RM, Walkenhorst H et al (2012) Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol 167:212\u2013214","DOI":"10.1111\/j.1365-2133.2012.10813.x"},{"key":"3570_CR34","doi-asserted-by":"crossref","unstructured":"Sugiura K, Takeichi T, Kono M et al (2012) Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3'-repair exonuclease 1. J Invest Dermatol 132:2855\u20132857","DOI":"10.1038\/jid.2012.210"},{"key":"3570_CR35","doi-asserted-by":"crossref","unstructured":"Abe J, Izawa K, Nishikomori R et al (2013) Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome\/familial chilblain lupus. Rheumatology (Oxford) 52:406\u2013408","DOI":"10.1093\/rheumatology\/kes181"},{"key":"3570_CR36","doi-asserted-by":"crossref","unstructured":"Gunther C, Hillebrand M, Brunk J et al (2013) Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol 69:e179\u2013e181","DOI":"10.1016\/j.jaad.2013.04.020"},{"key":"3570_CR37","doi-asserted-by":"crossref","unstructured":"Yamashiro K, Tanaka R, Li Y et al (2013) A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus. J Neurol 260:2653\u20132655","DOI":"10.1007\/s00415-013-7084-y"},{"key":"3570_CR38","doi-asserted-by":"crossref","unstructured":"Gunther C, Berndt N, Wolf C et al (2014) Familial Chilblain Lupus Due to a Novel Mutation in the Exonuclease III Domain of 3' Repair Exonuclease 1 (TREX1). JAMA Dermatol, epub","DOI":"10.1001\/jamadermatol.2014.3438"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-3570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-014-3570-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-3570-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T17:49:16Z","timestamp":1566323356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-014-3570-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1007\/s00105-014-3570-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}